Description

BSE announces listing of 2000 Commercial Papers of Rs. 5 lakh each issued by Dalmia Cement (Bharat) Limited on private placement basis, effective November 12, 2025.

Summary

BSE has listed 2000 Commercial Papers issued by Dalmia Cement (Bharat) Limited on private placement basis with effect from November 12, 2025. The instruments have a face value of Rs. 5,00,000 each, rated CRISIL A1+ and IND A1+, with allotment date of November 11, 2025 and redemption date of February 10, 2026. IDBI Bank Limited serves as the Issuing and Paying Agent.

Key Points

  • Quantity: 2000 Commercial Papers
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,92,473.50 per unit
  • Scrip Code: 730542
  • Scrip ID: DCL111125
  • ISIN: INE755K14FP0
  • Credit Rating: CRISIL A1+, IND A1+
  • Market Lot: 1
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE755K14FP0
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members should contact BSE debt department (22728352/8597/8995/5753/8915) for clarifications

Important Dates

  • Allotment Date: November 11, 2025
  • Listing Date: November 12, 2025
  • Redemption Date: February 10, 2026
  • Tenure: 91 days (approximately 3 months)

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The listing provides Dalmia Cement (Bharat) Limited with short-term funding through the debt market. Impact is limited to:

  • Debt market participants who may trade these instruments
  • The issuing company’s treasury operations
  • No impact on equity markets or retail investors

The high credit rating (A1+) indicates low credit risk. The short 3-month tenure is typical for commercial paper used for working capital requirements.

Impact Justification

Routine commercial paper listing with no impact on equity markets or broader regulatory compliance; relevant only to debt market participants and the issuing company.